continuous 60-hour infusion of PBO, BRX 60 mg/kg/hour (BRX60), or 90 mg/kg/hour (BRX90) and were followed through Day 30.
OBJECTIVE: Data on the association between antenatal depression and adverse pregnancy outcomes (APO) are conflicting. However, studies have typically evaluated the cross-sectional prevalence of depression rather than the trajectory of depressive symptoms across gestation. Our objective was to identify whether various trajectories of antenatal depressive symptoms are associated with differing risks of APO. STUDY DESIGN: This is a secondary analysis of a large multi-site prospective cohort of nulliparous women across the United States. Edinburgh Postpartum Depression Scale (EPDS) was administered at two study visits: between 6-14 weeks and again between 22-30 weeks gestation. The EPDS scores were categorized as improving, staying stable, or worsening based on whether the scores changed by at least one standard deviation (four points) across the two visits. The frequencies of APO (gestational diabetes, hypertensive disorders of pregnancy, abruption, cesarean delivery, preterm birth, small for gestational age neonates, NICU admission, and maternal readmission) were compared across depression trajectories in bivariable and multivariable analyses. RESULTS: Of the 8,784 women who completed both EPDS screens, 1141 (13.0%) had improved, 6663 (75.9%) stable, and 980 (11.2%) worsened scores across gestation. Compared with women with improving or stable scores, women with worsening scores were more likely to experience preterm birth and deliver a small for gestational age infant (Table 1) . After controlling for potential confounders, worsening score remained associated with preterm birth (aOR 1.68, 95% CI 1.10-2.57) ( Table 2) 
